Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2025)
Ernexa Therapeutics (ERNAW) reported Treasury Shares of $456000.0 for Q4 2020, little changed on a YoY basis from $456000.0 in Q1 2020, and little changed quarter-over-quarter from $456000.0 in Q3 2020.
Ernexa Therapeutics (ERNAW) Treasury Shares (2010 - 2025) Analysis & Trends
Ernexa Therapeutics has reported Treasury Shares for 11 years, with the latest figure at $456000.0 in Q4 2020.
- For the quarter ending Q4 2020, Treasury Shares changed 0.0% year-over-year to $456000.0; the trailing twelve-month figure through Dec 2020 stood at $456000.0 (changed 0.0% YoY), and the FY2020 full-year result was $456000.0, changed 0.0% from the prior year.
- Treasury Shares for Q4 2020 stood at $456000.0, roughly flat from $456000.0 in the prior quarter.
- The five-year high for Treasury Shares was $587000.0 in Q2 2022, with the low at $500.0 in Q1 2025.
- Historically, Treasury Shares has averaged $59375.0 across 5 years, with a median of $2500.0 in 2022.
- The largest YoY upside for Treasury Shares was 0.0% in 2016 against a maximum downside of 0.0% in 2016.
- Ernexa Therapeutics' Treasury Shares stood at $456000.0 in 2016, then changed by 0.0% to $456000.0 in 2017, then changed by 0.0% to $456000.0 in 2018, then changed by 0.0% to $456000.0 in 2019, then changed by 0.0% to $456000.0 in 2020.
- The last three Treasury Shares figures came in at $456000.0 (Q4 2020), $456000.0 (Q3 2020), and $456000.0 (Q1 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ernexa Therapeutics | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 500.00 |
| Mar 31, 2025 | 500.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Sep 30, 2022 | 15,000.00 |